1. Home
  2. PRQR vs VWAV Comparison

PRQR vs VWAV Comparison

Compare PRQR & VWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.55

Market Cap

166.5M

Sector

Health Care

ML Signal

HOLD

VWAV

VisionWave Holdings Inc.

HOLD

Current Price

$4.22

Market Cap

139.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRQR
VWAV
Founded
2012
2024
Country
Netherlands
United States
Employees
N/A
12
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
166.5M
139.7M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
PRQR
VWAV
Price
$1.55
$4.22
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$7.25
N/A
AVG Volume (30 Days)
1.0M
555.0K
Earning Date
05-07-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$2.06
52 Week High
$3.10
$15.80

Technical Indicators

Market Signals
Indicator
PRQR
VWAV
Relative Strength Index (RSI) 46.38 39.42
Support Level $1.39 N/A
Resistance Level $1.70 $6.47
Average True Range (ATR) 0.16 0.53
MACD 0.01 -0.09
Stochastic Oscillator 30.95 8.00

Price Performance

Historical Comparison
PRQR
VWAV

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

About VWAV VisionWave Holdings Inc.

VisionWave Holdings Inc is a technology company focused on the development and commercialization of artificial intelligence (AI) and autonomous solutions across air, ground and sea environments. Through its subsidiary, the Company designs and deploys technologies including radars, radio frequency (RF) sensing, unmanned aerial and ground systems, remote weapon stations and active protection systems for defense, military, homeland security and industrial applications. Its proprietary AI engine supports autonomous decision-making and product lines at various stages of development and commercialization. Revenue is generated through product sales, technology licensing, strategic alliances and joint ventures, with products including C-UAS, multi-purpose autonomous UAS and Vision-AI technology.

Share on Social Networks: